School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Center for Health Economics and Policy Studies, Faculty of Public Health, Universitas Indonesia, Jakarta, Indonesia.
BMC Public Health. 2024 Jan 2;24(1):71. doi: 10.1186/s12889-023-17568-6.
The COVID-19 pandemic has disrupted healthcare utilization globally, but little is known about the effects among patients with cardiovascular diseases (CVDs) and other multimorbidities. This study analyzed the impacts of COVID-19 on healthcare utilization for patients aged 30 years and older with cardiovascular diseases (CVDs) with or without other chronic disease comorbidities in Indonesia.
We designed a retrospective cohort study based on the Indonesian National Health Insurance (NHI) sample data from 2016-2020. We defined healthcare utilization as monthly outpatient and inpatient visits related to chronic diseases at the hospital and primary healthcare levels per 10,000 NHI members. We used interrupted time series analysis to evaluate how the healthcare utilization patterns had changed due to the COVID-19 pandemic.
Overall, hospital outpatient visits decreased by 39% when the pandemic occurred (95% Confidence Interval (CI): 0.48,0.76), inpatient visits by 28% (95% CI: 0.62,0.83), and primary healthcare visits by 34% (95% CI:0.55, 0.81). For patients with CVDs and multimorbidity, hospital outpatient and inpatient visit rates were reduced by 36% and 38%, respectively and primary healthcare visits by 32%. Some insignificant differences in the reduction of out-and inpatient visits were observed across diagnosis groups and regions.
Healthcare utilization among patients with chronic diseases decreased significantly during COVID-19 and consistently across different chronic diseases and regions. To cope with the unmet needs of healthcare utilization in the context of the pandemic, the healthcare system needs to be strengthened to cater to the needs of the population-at-risk, especially for patients with CVDs and multimorbidity.
新冠疫情在全球范围内扰乱了医疗保健的利用,但是对于心血管疾病(CVDs)和其他多种合并症患者的影响知之甚少。本研究分析了 COVID-19 对印度尼西亚 30 岁及以上患有 CVDs 且伴有或不伴有其他慢性疾病合并症患者的医疗保健利用的影响。
我们根据 2016-2020 年印度尼西亚国家健康保险(NHI)样本数据设计了一项回顾性队列研究。我们将医疗保健利用定义为每 10000 名 NHI 成员在医院和初级保健层面与慢性病相关的每月门诊和住院就诊次数。我们使用中断时间序列分析来评估由于 COVID-19 大流行,医疗保健利用模式发生了怎样的变化。
总体而言,大流行发生时,医院门诊就诊次数减少了 39%(95%置信区间(CI):0.48,0.76),住院就诊次数减少了 28%(95% CI:0.62,0.83),初级保健就诊次数减少了 34%(95% CI:0.55,0.81)。对于患有 CVD 和多种合并症的患者,医院门诊和住院就诊率分别降低了 36%和 38%,初级保健就诊率降低了 32%。在不同的诊断组和地区,门诊和住院就诊次数减少的差异并不显著。
COVID-19 期间,慢性病患者的医疗保健利用显著减少,且在不同的慢性病和地区之间具有一致性。为了应对大流行背景下医疗保健利用的未满足需求,医疗保健系统需要加强,以满足高危人群的需求,特别是患有 CVD 和多种合并症的患者。